Teva- Pharmaceutical Industries Ltd.

NYSE: TEVA
Share price (5/17/24): $16.29
Market cap (5/17/24): $18.3 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

12 Teva- Pharmaceutical Industries Ltd. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of ADR shares, immediately effective

Prospectus supplement for primary offering

Ownership Filter

Phoenix Holdings Ltd.

Kalif Eliyahu Sharon

News Filter

Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations

Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook

The Following Tables Present Revenues, Expenses and Profit for Each Segment for the Years Ended December 31, 2023 and 2022, and for the Three Months Ended December 31, 2023, September 30, 2023, June 30, 2023 and March 31, 2023

Reports Growth in Fourth Quarter and Full Year 2023

Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance 2023 Revenues Outlook Revised to $15.1 - $15.5 Billion From $15.0 - $15.4 Billion

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Letter from the SEC

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Conflict Minerals disclosure